Basit öğe kaydını göster

dc.contributor.authorBicakcigil, M
dc.contributor.authorAkar, S
dc.contributor.authorÖnen, F
dc.contributor.authorSeyahi, E
dc.contributor.authorOnat, AM
dc.contributor.authorAydin, SZ
dc.contributor.authorYilmaz, N
dc.contributor.authorCefle, A
dc.contributor.authorCobankara, V
dc.contributor.authorTunc, E
dc.contributor.authorOzturk, MA
dc.contributor.authorFresko, I
dc.contributor.authorKaraaslan, Y
dc.contributor.authorAkkoc, N
dc.contributor.authorYücel, AE
dc.contributor.authorKiraz, S
dc.contributor.authorKeser, G
dc.contributor.authorInanc, M
dc.contributor.authorSaruhan-Direskeneli, Güher
dc.contributor.authorUyar, Fatma Aytül
dc.contributor.authorDireskeneli, H
dc.contributor.authorTuna-Erdoğan, E
dc.contributor.authorGündüz, F
dc.contributor.authorBandurska-Luque, A
dc.contributor.authorAlparslan, B
dc.contributor.authorKebe, M
dc.contributor.authorAksu, K
dc.contributor.authorKamali, S
dc.contributor.authorOzbalkan, Z
dc.contributor.authorAtes, A
dc.contributor.authorKaradag, O
dc.contributor.authorOzer, HT
dc.date.accessioned2021-03-04T11:17:53Z
dc.date.available2021-03-04T11:17:53Z
dc.identifier.citationDireskeneli H., Tuna-Erdoğan E., Gündüz F., Bandurska-Luque A., Alparslan B., Kebe M., Uyar F. A. , Bicakcigil M., Aksu K., Kamali S., et al., "PDCD1 polymorphisms are not associated with Takayasu's arteritis in Turkey", Clinical and Experimental Rheumatology, cilt.30, 2012
dc.identifier.issn0392-856X
dc.identifier.othervv_1032021
dc.identifier.otherav_71a06fd6-d174-4cb5-b917-81da91359385
dc.identifier.urihttp://hdl.handle.net/20.500.12627/78236
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84863735129&origin=inward
dc.identifier.urihttps://doi.org/10.1007/s00296-011-2127-0
dc.description.abstractObjectives: Takayasu's arteritis (TA) is a chronic arterial inflammation of unknown etiology involving mainly the aorta and its major branches. Based on the associations of programmed death-1 (PD-1) protein encoding gene (PDCD1) with connective tissue diseases and vasculitides, PDCD1 polymorphisms are studied for susceptibility to TA in this study. Methods: The study group is made up of TA patients (n=229) fulfilling the 1990 ACR classification criteria and compared to 193 healthy controls (HC). PD-1.3, PD-1.5 and PD-1.6 single nucleotide polymorphisms of PDCD1 gene are genotyped by polymerase chain reaction and restriction analysis (PCR-RFLP). Results: The distribution of PD-1.5 polymorphism in TA patients and HC revealed a similar presence of TT genotype in patients and controls (13.3% vs. 11.4%). PD-1.3 and PD-1.6 were less polymorphic and did not differ between the groups. Rare AA genotype of PD-1.3 (1.4% vs. 1.0%) and AG genotype of PD-1.6 was again similarly (22.4% vs. 19.2%) present in TA and HC. Conclusion: PD-1.3, 1.5 and 1.6 polymorphisms of PDCD1 gene, which were shown to be associated with various autoimmune disorders and vasculitides, are not associated with a susceptibility to TA in Turkish population. © Clinical and Experimental Rheumatology 2012.
dc.language.isoeng
dc.titlePDCD1 polymorphisms are not associated with Takayasu's arteritis in Turkey
dc.typeMakale
dc.relation.journalClinical and Experimental Rheumatology
dc.contributor.department, ,
dc.identifier.volume30
dc.contributor.firstauthorID718236


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster